We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Antiviral activity of micafungin against enterovirus 71.
- Authors
Chonsaeng Kim; Hyunju Kang; Dong-eun Kim; Jae-Hyoung Song; Miri Choi; Mingu Kang; Kyungjin Lee; Hae Soo Kim; Jin Soo Shin; Hyejeong Jeong; Sunhee Jung; Sang-Bae Han; Jong Heon Kim; Hyun-Jeong Ko; Chong-Kyo Lee; Meehyein Kim; Sungchan Cho
- Abstract
Background: Enterovirus 71 (EV71) is a major causative agent of hand-foot-mouth disease (HFMD) and also causes severe neurological complications, leading to fatality in young children. However, no effective therapy is currently available for the treatment of this infection. Methods: We identified small-molecule inhibitors of EV71 from a screen of 968 Food and Drug Administration (FDA)-approved drugs, with which clinical application for EV71-associated diseases would be more feasible, using EV71 subgenomic replicon system. Primary hits were extensively evaluated for their antiviral activities in EV71-infected cells. Results: We identified micafungin, an echinocandin antifungal drug, as a novel inhibitor of EV71. Micafungin potently inhibits the proliferation of EV71 as well as the replication of EV71 replicon in cells with a low micromolar IC50 (~5 μM). The strong antiviral effect of micafungin on EV71 replicon and the result from time-of-addition experiment demonstrated a targeting of micafungin on virion-independent intracellular process(es) during EV71 infection. Moreover, an extensive analysis excluded the involvement of 2C and 3A proteins, IRES-dependent translation, and also that of polyprotein processing in the antiviral effect of micafungin. Conclusions: Our research revealed a new indication of micafungin as an effective inhibitor of EV71, which is the first case reporting antiviral activity of micafungin, an antifungal drug.
- Subjects
ENTEROVIRUSES; ANTIFUNGAL agents; HAND, foot &; mouth disease; ANTIVIRAL agents; DRUG approval; UNITED States. Food &; Drug Administration
- Publication
Virology Journal, 2016, Vol 13, Issue 1, p1
- ISSN
1743-422X
- Publication type
Article
- DOI
10.1186/s12985-016-0557-8